Quarterly report pursuant to Section 13 or 15(d)

Transactions Affecting Stockholders' Equity (Details Narrative)

v3.20.2
Transactions Affecting Stockholders' Equity (Details Narrative)
3 Months Ended 9 Months Ended
Sep. 15, 2020
$ / shares
shares
Dec. 12, 2019
$ / shares
Jan. 24, 2019
USD ($)
$ / shares
Dec. 24, 2018
$ / shares
Sep. 05, 2018
$ / shares
Apr. 12, 2018
USD ($)
$ / shares
shares
Sep. 30, 2020
USD ($)
$ / shares
shares
Sep. 30, 2019
shares
Sep. 30, 2020
USD ($)
$ / shares
shares
Sep. 30, 2019
USD ($)
shares
Dec. 31, 2019
$ / shares
shares
May 05, 2010
shares
Common stock, shares authorized             50,000,000   50,000,000   50,000,000  
Common stock, par value | $ / shares             $ 0.0005   $ 0.0005   $ 0.0005  
Preferred stock, shares authorized             1,000,000   1,000,000   1,000,000  
Preferred stock, par value | $ / shares             $ 0.0005   $ 0.0005   $ 0.0005  
Preferred stock, shares issued                  
Cash dividend, per shares | $ / shares       $ 0.25                
Payments of dividends | $                 $ 2,929,000    
Share based compensation | $                 $ 669,000      
Stock options weighted average period                 1 year 7 months 6 days      
2010 Directors' Equity Compensation Plan [Member]                        
Plan provides total number of shares of common stock issued                       675,000
Stock option granted             212,605 4,727 230,660 15,464    
Director fees | $                 $ 108,000 $ 45,000    
Stock issued during period shares                 200,000      
2010 Equity Compensation Plan [Member]                        
Plan provides total number of shares of common stock issued                       3,900,000
Stock option granted             250,000 250,000    
Stock option exercised                
Options outstanding - shares             1,032,000   1,032,000      
Available for grant, shares             278,659   278,659      
2018 Stock Incentive Plan [Member]                        
Stock option granted           2,300,000            
Share based compensation | $           $ 188,000            
Stock options weighted average period           4 months 24 days            
Stock option exercise price per share | $ / shares           $ 3.00            
Stock option exercisable           36 months            
2018 Stock Plan [Member] | CEO Option [Member]                        
Stock option exercise price per share | $ / shares   $ 1.50 $ 1.75   $ 2.00              
Stock option plan, reduced exercise price per share, description   The exercise price of the CEO Option was further reduced from $1.75 to $1.50 per share, effective as of December 12, 2019, The exercise price of the CEO Option was further reduced from $2.00 to $1.75 per share.   Exercise price of the CEO Option was reduced from $3.00 per share to $2.00 per share.              
2018 Stock Plan [Member] | CEO Option [Member] | Stock Holders [Member]                        
Cash dividend, per shares | $ / shares   $ 0.25 $ 0.25   $ 1.00              
Common Stock [Member]                        
Payments of dividends | $     $ 2,900,000                  
Common Stock [Member] | 2010 Directors' Equity Compensation Plan [Member]                        
Stock issued during period shares                 128,126      
Warrant [Member]                        
Stock issued during period shares 200,000                      
Share based compensation | $             $ 16,000   $ 16,000      
Warrants exercise price per share | $ / shares $ 3                      
Warrants outstanding shares             400,000   400,000      
Fair value of warrants | $                 $ 372,000      
Expected term of warrants 2 years                      
Warrant [Member] | Weighted Average Risk Rate [Member]                        
Measurement input in determining fair value 0.16                      
Warrant [Member] | Dividend Yield [Member]                        
Measurement input in determining fair value 0                      
Warrant [Member] | Expected Volatility [Member]                        
Measurement input in determining fair value 56.21